phloroglucinol has been researched along with Cirrhosis in 1 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrosis is a highly prevalent disease, which is responsible for 45% of deaths through pathological effects in developed countries." | 5.56 | Combined treatment of low-level laser therapy and phloroglucinol for inhibition of fibrosis. ( Ahn, JC; Hong, N; Kang, HW; Kim, H; Lee, Y, 2020) |
| "Fibrosis is a highly prevalent disease, which is responsible for 45% of deaths through pathological effects in developed countries." | 1.56 | Combined treatment of low-level laser therapy and phloroglucinol for inhibition of fibrosis. ( Ahn, JC; Hong, N; Kang, HW; Kim, H; Lee, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, Y | 1 |
| Kim, H | 1 |
| Hong, N | 1 |
| Ahn, JC | 1 |
| Kang, HW | 1 |
1 other study available for phloroglucinol and Cirrhosis
| Article | Year |
|---|---|
Combined treatment of low-level laser therapy and phloroglucinol for inhibition of fibrosis.
Topics: Animals; Cells, Cultured; Fibroblasts; Fibrosis; Low-Level Light Therapy; Mice; NIH 3T3 Cells; Phlor | 2020 |